Rajesh Kumar

Stock Analyst at HSBC

(2.50)
# 2,125
Out of 5,182 analysts
33
Total ratings
42.86%
Success rate
5.71%
Average return

Stocks Rated by Rajesh Kumar

Eli Lilly and Company
Mar 17, 2026
Downgrades: Reduce
Price Target: $1,070$850
Current: $868.27
Upside: -2.10%
Pfizer
Mar 17, 2026
Maintains: Buy
Price Target: $29$32
Current: $26.79
Upside: +19.45%
Biogen
Mar 17, 2026
Maintains: Reduce
Price Target: $143$150
Current: $180.67
Upside: -16.98%
Bristol-Myers Squibb Company
Mar 17, 2026
Maintains: Hold
Price Target: $53$60
Current: $57.78
Upside: +3.84%
AbbVie
Dec 10, 2025
Upgrades: Buy
Price Target: $225$265
Current: $197.38
Upside: +34.26%
Novo Nordisk
Nov 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $41.20
Upside: -
IQVIA Holdings
Oct 9, 2025
Upgrades: Buy
Price Target: $195$235
Current: $163.84
Upside: +43.43%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36$42
Current: $28.15
Upside: +49.20%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660$670
Current: $468.04
Upside: +43.15%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250$280
Current: $180.62
Upside: +55.02%
Upgrades: Hold
Price Target: $460
Current: $354.69
Upside: +29.69%
Initiates: Buy
Price Target: $13
Current: $31.26
Upside: -58.41%
Initiates: Reduce
Price Target: $97
Current: $48.70
Upside: +99.18%
Initiates: Buy
Price Target: $124
Current: $102.06
Upside: +21.50%
Initiates: Hold
Price Target: $123
Current: $110.23
Upside: +11.58%